Nanobac Pharmaceuticals Incorporated (NNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 0 | 10 | 220 | 650 | 350 |
| Cost of Goods | N/A | 10 | 80 | 220 | 100 |
| Gross Profit | N/A | 3 | 140 | 420 | 250 |
| Operating Expenses | 0 | 4,910 | 4,440 | 3,480 | 7,940 |
| Operating Income | N/A | -4,900 | -4,220 | -2,830 | -7,590 |
| Interest Expense | 0 | 180 | 190 | 70 | 240 |
| Other Income | 0 | -1,490 | -560 | -780 | 20 |
| Pre-tax Income | 0 | -6,570 | -4,970 | -3,680 | -7,810 |
| Net Income Continuous | N/A | -6,570 | -4,970 | -3,680 | -7,810 |
| Net Income Discontinuous | N/A | 0 | 0 | 0 | -50 |
| Net Income | $N/A | $-6,570 | $-4,970 | $-3,680 | $-7,870 |
| EPS Basic Total Ops | N/A | -0.03 | -0.03 | -0.02 | -0.05 |
| EPS Basic Continuous Ops | N/A | -0.03 | -0.03 | -0.02 | -0.05 |
| EBITDA(a) | $N/A | $-4,440 | $-3,680 | $-2,070 | $-6,880 |